SARS-CoV-2 Antibodies Recognize 23 Distinct Epitopic Sites on the Receptor Binding Domain

To gain insight into the immunogenic characteristics of epitopic sites, researchers systematically investigated the structures of 340 Abs and 83 nanobodies complexed with the Receptor Binding Domain of the SARS-CoV-2 spike protein.